Alkem Labs sees Rs 300 crore worth equity change hands in large deal

Alkem Labs shares are down over 16 percent year-to-date.

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Shares of Alkem Labortories fell in opening trade on February 21 after a large deal worth Rs 300 crore took place on the exchanges. As much as 6.41 lakh shares of the drugmaker were sold through the large deal at a floor price of Rs 4,680 apiece. The floor price of the large deal reflected a marginal discount from the Thursday closing price of the stock.

Moneycontrol could not immediately identified the buyers and sellers involved in the transaction.

At 09.16 am shares of Alkem Labs were trading at Rs 4,700.50 on the NSE. Alkem Labs shares are down over 16 percent year-to-date.

Follow our market blog to catch all the live action

The company is also suffering from a slowdown in anti-infective therapy within the Indian pharma market, a segment where Alkem has a strong hold. Brokerage firm Nuvama Institutional Equities noted that a the slowdown in anti-infective therapy continues to play negatively for Alkem, as seen in Q3.

The management also acknowledged this slowdown as a key headwind for the drugmaker. However, Nuvama pointed out other comments from the management that emerged as key positives from Alkem's Q3 earnings. These factors include improved gross margins, lower raw material prices, an expected 13-14 percent growth in non-US markets, and the GLP-1 submission already presented to the Indian regulator.

In Q3, Alkem Laboratories posted a 5 percent year-on-year increase in net profit, coming at Rs 626 crore for the December quarter, up from Rs 595 crore in the same period last year.

Revenue from operations recorded a marginal 1.5 percent rise to Rs 3,374 crore, compared to Rs 3,324 crore a year ago. Meanwhile, EBITDA margin improved by 120 basis points to 22.5 percent from 21.3 percent in the previous year.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.